Navigation Links
ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
Date:8/7/2008

ix Months Ended

June 30, June 30,

2008 2007 2008 2007

Revenue

Product sales, net $17,691 $13,518 $33,145 $23,701

License revenue 70 70 139 139

Total revenue 17,761 13,588 33,284 23,840

Cost of products sold 4,766 3,687 8,955 6,220

Gross profit margin 12,995 9,901 24,329 17,620

Operating expenses:

Research and

development 7,472 6,012 17,287 12,565

Selling, general, and

administrative 13,302 11,967 26,952 24,057

Total operating expenses 20,774 17,979 44,239 36,622

Loss from operations (7,779) (8,078) (19,910) (19,002)

Interest (expense)/

income, net (680) (665) (1,504) (1,192)

Net loss $(8,459) $(8,743) $(21,414) $(20,194)

Net loss per common share,

basic and diluted $(0.26) $(0.32) $(0.65) $(0.76)

Shares used in computing

net loss per common share,

basic and diluted 33,029 26,935 33,008 26,608

ISTA Pharmaceuticals, Inc.

Summary of Consolidated Balance Sheets Data

(in thousands)

(unaudited)

June 30,2008 December 31,2007

Cash and short-term investments $21,782 $46,140

Restricted cash 800 2,400

Working capital (30,409)
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Solutions , Inc. (NASDAQ: BLFS ), a leading ... storage and cryopreservation freeze media and ... or the "Company"), today announced that it will hold its ... "Annual Meeting"). Because the expected date for the ...
(Date:12/24/2014)... 23, 2014 GMO corn cases filed across ... in the process of being consolidated in a Kansas federal ... Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 in ... Management of the Syngenta GMO corn multidistrict litigation (MDL) has ...
(Date:12/24/2014)... 23, 2014 SoundConnect’s ... introduce cutting edge communication technology, provide continued education ... This webinar series demonstrates online communication features and ... web conferencing’s most innovative and powerful tools. , ...
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... announced today that Chairman and CEO Fred Hassan purchased,just ... 000 shares at,an average purchase price of $18.26 per ... intention to purchase these shares in,January, this investment in ... -- including ZETIA and VYTORIN --,and our late- stage ...
... The Board of,Directors of Shire plc (LSE: ... company, announces today that Michael Rosenblatt M.D.,will join ... effect., Dr Rosenblatt is the Dean of ... previously Professor of Medicine at Harvard,Medical School and ...
... S.A. announced today that it,has repurchased the Isobar ... Scient,x the ultimate exclusive holder of the of ... Scient,x was first,to market in the spinal implant ... worldwide Scient,x has the longest clinical track,record with ...
Cached Biology Technology:Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4Scient'x Re-Acquires Isobar License 2
(Date:1/22/2015)...  Today, FreeWavz ( www.FreeWavz.com ), the developer of ... Fundable, https://www.fundable.com/freewavz . FreeWavz will be expanding ... meet customer demand. Logo - ... Invented by Dr. Eric ...
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... Molecular Biology Organization (EMBO) proudly announces the introduction ... journal dedicated to a research discipline focused on ... The new journal, launching in 2009, will publish ... systemic processes underlying defined human diseases as well ...
... rice genome has been developed by researchers at UC ... The inexpensive, publicly-available rice DNA microarray covers nearly all ... published this week in the open-access journal PLoS ... or rice plants, each cell type express different genes ...
... 3-D structure of the virus, known as Seneca Valley Virus-001, ... the Picornaviridae viral family, and confirms its recent designation as ... virus,s outer protein shell looks like a craggy golf ballone ... it is arranged in a round mesh rather like a ...
Cached Biology News:Scripps research team solves structure of 'beneficial' virus 2
Purified anti-DNA-PKcs Phosphorylated (Thr2609)...
Purified anti-PI3K p110 delta...
Biotin anti-mouse Ly-49C/F/I/H...
... Tyrosine Hydroxylase (Ser40) Polyclonal Antibody ... against synthetic phosphopeptide corresponding to ... phospho-Ser40 of rat Tyrosine Hydroxylase ... by sequential chromatography on phospho- ...
Biology Products: